Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study.
about
Advances in refractory ulcerative colitis treatment: A new therapeutic target, Annexin A2Glucose intolerance and diabetes mellitus in ulcerative colitis: pathogenetic and therapeutic implicationsReview article: problematic proctitis and distal colitisAcute toxicity and gastroprotection studies with a newly synthesized steroidEfficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-AnalysisHistologic scoring indices for evaluation of disease activity in ulcerative colitis.Influence of oral beclomethasone dipropionate on early non-infectious pulmonary outcomes after allogeneic hematopoietic cell transplantation: results from two randomized trials.Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis.Novel drug delivery strategies for the treatment of inflammatory bowel disease.Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials.Update in the treatment of paediatric ulcerative colitis.Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity.Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation.Treatment of inflammatory bowel disease: a review of medical therapy.Clinical Efficacy of Beclomethasone Dipropionate in Korean Patients with Ulcerative Colitis.Treatment of steroid-naive ulcerative colitis.Efficacy and safety of drugs for ulcerative colitis.Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis.Oral locally active steroids in inflammatory bowel disease.Second-generation corticosteroids for the treatment of Crohn's disease and ulcerative colitis: more effective and less side effects?Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis.Low bioavailability steroids in inflammatory bowel disease: an old chestnut or a whole new ballgame?"Mucosal healing" in ulcerative colitis: Between clinical evidence and market suggestion.New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?New treatment strategies for ulcerative colitis.The safety of non-biological treatments in Ulcerative Colitis.Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis.Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa.Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study.Recent advances in the management of distal ulcerative colitis.Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU Study.Histological healing in inflammatory bowel disease: a still unfulfilled promise.Accuracy of Rapid Fecal Calprotectin Test in Monitoring Inflammatory Bowel Diseases Under Treatment with TNFα Antagonists.Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study.Oral prolonged release beclomethasone dipropionate and prednisone in the treatment of active ulcerative colitis: results from a double-blind, randomized, parallel group study.Mucosal expression of basic fibroblastic growth factor, Syndecan 1 and tumor necrosis factor-alpha in diverticular disease of the colon: a case-control study.Rapid fecal calprotectin correlates with clinical and endoscopic severity of inflammatory bowel diseases.
P2860
Q26798299-241B02C7-5D4D-4582-9632-699131D2A09FQ26866110-13D020A6-F25A-4196-9DCF-3219DEED38C0Q28280774-A08BA6A1-E2F4-4E10-A0B0-7C1B25B2273DQ28487974-B9DF135F-FE0C-485D-BFE2-8C3E146C54D8Q28553419-DAE28C95-8693-4DDD-8A0D-12DC945AC4ADQ30234366-2012911E-F3D6-4C51-BE7E-C7CB3AF4B32EQ33645826-4F66B804-5AD4-4170-B246-D8B1C93DD641Q35233808-A4D58D25-0068-44C3-8DEB-2FB93B08C8E6Q36193009-51610F70-8B5E-4930-819F-ACF5FEBE04B0Q36316765-3CE17E62-1BCB-4CCE-A4B0-89A4657FB6F0Q36609208-FFF7B265-718A-4F49-B138-895FA884CC6DQ36613876-DC79072E-ED5D-48C4-A8C2-ABF3A2DEDBE5Q36659176-7023B818-EC2A-49E9-9A2D-F49C60194472Q36964735-D9135D34-6895-4D21-ADCB-BCA9B7CCF353Q37058862-024FFD4D-ABB2-4C08-9F20-A029CE7ADAA8Q37438305-621F4973-EF96-4BC0-98A6-08E07F822848Q37483916-BDBEED93-CC81-452D-A4FF-53BC331A9913Q37727232-0BE86489-B400-4F7C-9AD9-2B9E787B14E9Q37853356-0745D4D8-2FB4-4544-A189-E1AF6C1E6D4BQ38025531-69D541B8-143E-4EC9-A611-8C7593890428Q38026396-C3CE19C9-3207-4D56-9CA9-AF81E0302B80Q38196945-2FF0219D-B36E-492B-AAB2-F8FB6339917BQ38216510-47828361-FFF4-4D3C-BB0C-895A9AD5F32BQ38217234-2178AFBD-444E-4280-A1D1-795D1C0C8245Q38625992-905626EB-7467-43E4-A4C8-017465E6B0CDQ38670811-B0908949-60A3-4978-B24A-F2828B5004C8Q38728164-CFFC17BC-1392-455C-8970-A20B99ED25FCQ38960072-4E25C239-B8EB-457D-BFC9-4F2A065C070AQ39098635-F1EC0C8D-C0F9-4E54-8075-F50884A2F65DQ39170844-877BA2AF-9B07-409C-AF59-D42F5ACF3A3AQ40046590-864BBB4F-ACC3-46D4-AD3B-9205637F4721Q40525397-6C670EEF-D74A-42CE-8495-7F38CC3759CFQ42730491-C424C371-7872-4511-B12E-58D3DC488FCAQ42788626-41BF9B7F-6DAC-4369-A133-F68D4359FFC9Q43240077-FC15DA4B-5BB1-434A-BB21-127F4D868150Q44405203-FBC7F665-973D-4DDB-845C-13050F7C8776Q44488900-6BCB1777-917A-4E9F-AC08-66F6ABF46E4BQ44755570-87501CA6-9B4F-4E44-B7E8-6A7B8210BE4CQ45002802-E3A9475E-592E-4C46-82AF-43ED864E8906Q45023483-540E41EA-1B3D-4AE4-BA7D-C5EE9197B37E
P2860
Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Oral beclometasone dipropionat ...... lind placebo-controlled study.
@en
Oral beclometasone dipropionat ...... lind placebo-controlled study.
@nl
type
label
Oral beclometasone dipropionat ...... lind placebo-controlled study.
@en
Oral beclometasone dipropionat ...... lind placebo-controlled study.
@nl
prefLabel
Oral beclometasone dipropionat ...... lind placebo-controlled study.
@en
Oral beclometasone dipropionat ...... lind placebo-controlled study.
@nl
P2093
P2860
P50
P1476
Oral beclometasone dipropionat ...... blind placebo-controlled study
@en
P2093
A D'Arienzo
D Valpiani
G Di Matteo
G N Castiglione
P2860
P304
P356
10.1046/J.1365-2036.2002.01298.X
P407
P577
2002-06-01T00:00:00Z